Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.420
+0.090 (2.08%)
At close: Jul 11, 2025, 4:00 PM
4.370
-0.050 (-1.13%)
After-hours: Jul 11, 2025, 7:43 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $159.06 million as of July 11, 2025. Its market cap has increased by 275.10% in one year.
Market Cap
159.06M
Enterprise Value
127.27M
1-Year Change
275.10%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $159.06M, a decrease of -56.52%. That is a compound annual growth rate of -19.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 159.06M | 132.84% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |